Back to Search Start Over

Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1

Authors :
Ken‐ichi Yasuda
Yoshimasa Nobeyama
Takaoki Ishiji
Arihito Ota
Akihiko Asahina
Source :
Clinical Case Reports, Vol 8, Iss 11, Pp 2125-2128 (2020)
Publication Year :
2020
Publisher :
Wiley, 2020.

Abstract

Abstract Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.

Details

Language :
English
ISSN :
20500904
Volume :
8
Issue :
11
Database :
Directory of Open Access Journals
Journal :
Clinical Case Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.7c7980e28a9c45b79e6b97b82fb9b441
Document Type :
article
Full Text :
https://doi.org/10.1002/ccr3.3071